BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31719797)

  • 1. Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT.
    Wang B; Wang G; Wang Q; Zhu Z; Wang Y; Chen K; Yang H
    Cancer Cell Int; 2019; 19():284. PubMed ID: 31719797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripartite Motif Containing 11 Interacts with DUSP6 to Promote the Growth of Human Osteosarcoma Cells through Regulating ERK1/2 Pathway.
    Wang Z; Xu X; Tang W; Zhu Y; Hu J; Zhang X
    Biomed Res Int; 2019; 2019():9612125. PubMed ID: 31950060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination.
    Zhang P; Tang Y; Zhao J; Yang J; Chen Y; Gong Y; Meng S; Shu C
    Neoplasma; 2023 Oct; 70(5):659-669. PubMed ID: 38053376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripartite motif-containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin-proteasome-mediated degradation of pleckstrin homology domain leucine-rich repeats protein phosphatase 1.
    Yang J; Ye J; Ma T; Tang F; Huang L; Liu Z; Tian S; Cheng X; Zhang L; Guo Z; Tu F; He M; Xu X; Lu X; Wu Y; Zeng X; Zou J; Wang X; Peng W; Zhang P
    Hepatology; 2022 Sep; 76(3):612-629. PubMed ID: 34767673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM11 promotes proliferation and glycolysis of breast cancer cells via targeting AKT/GLUT1 pathway.
    Song W; Wang Z; Gu X; Wang A; Chen X; Miao H; Chu J; Tian Y
    Onco Targets Ther; 2019; 12():4975-4984. PubMed ID: 31388304
    [No Abstract]   [Full Text] [Related]  

  • 6. Knockdown of TRIM11 suppresses cell progression and apoptosis of cervical cancer cells via PI3K/AKT pathway.
    Liu W; Wu Z; Wang L; Wang Q; Sun X; Niu S
    Am J Transl Res; 2021; 13(9):10328-10340. PubMed ID: 34650700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction Note: Silencing of TRIM11 suppresses the tumorigenicity of chordoma cells through improving the activity of PHLPP1/AKT.
    Wang B; Wang G; Wang Q; Zhu Z; Wang Y; Chen K; Yang H
    Cancer Cell Int; 2023 Sep; 23(1):216. PubMed ID: 37752515
    [No Abstract]   [Full Text] [Related]  

  • 8. TRIM11 promotes lymphomas by activating the β-catenin signaling and Axin1 ubiquitination degradation.
    Hou Y; Ding M; Wang C; Yang X; Ye T; Yu H
    Exp Cell Res; 2020 Feb; 387(2):111750. PubMed ID: 31786079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation and invasion of ovarian cancer cells are suppressed by knockdown of TRIM11.
    Chen Y; Sun J; Ma J
    Oncol Lett; 2017 Aug; 14(2):2125-2130. PubMed ID: 28781653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PHLPP1 inhibits the growth and aerobic glycolysis activity of human ovarian granular cells through inactivating AKT pathway.
    Yang X; A M; Gegen T; Daoerji B; Zheng Y; Wang A
    BMC Womens Health; 2024 Jan; 24(1):25. PubMed ID: 38184561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.
    Wang J; Fang Y; Liu T
    Biomed Res Int; 2020; 2020():4027627. PubMed ID: 32051827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ARHGAP10 Inhibits the Proliferation and Metastasis of CRC Cells via Blocking the Activity of RhoA/AKT Signaling Pathway.
    Liu L; Xie D; Xie H; Huang W; Zhang J; Jin W; Jiang W; Xie D
    Onco Targets Ther; 2019; 12():11507-11516. PubMed ID: 31920339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer.
    Tang J; Tian Z; Liao X; Wu G
    Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USP1 regulates AKT phosphorylation by modulating the stability of PHLPP1 in lung cancer cells.
    Zhiqiang Z; Qinghui Y; Yongqiang Z; Jian Z; Xin Z; Haiying M; Yuepeng G
    J Cancer Res Clin Oncol; 2012 Jul; 138(7):1231-8. PubMed ID: 22426999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway.
    Diao W; Guo Q; Zhu C; Song Y; Feng H; Cao Y; Du M; Chen H
    BMC Cancer; 2020 Aug; 20(1):741. PubMed ID: 32770981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells.
    Wang X; Shi W; Shi H; Lu S; Wang K; Sun C; He J; Jin W; Lv X; Zou H; Shu Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):100. PubMed ID: 27329103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA XIST Promotes Growth of Human Chordoma Cells by Regulating miR-124-3p/iASPP Pathway.
    Hai B; Pan X; Du C; Mao T; Jia F; Liu Y; Ma Y; Liu X; Zhu B
    Onco Targets Ther; 2020; 13():4755-4765. PubMed ID: 32547104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM27 promotes the development of esophagus cancer via regulating PTEN/AKT signaling pathway.
    Ma L; Yao N; Chen P; Zhuang Z
    Cancer Cell Int; 2019; 19():283. PubMed ID: 31719796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tripartite motif protein 11 (TRIM11), an oncogene for human lung cancer via the DUSP6-mediated ERK1/2 signaling pathway.
    Wang XL; Lu SC; Sun C; Jin WG; Fan YW; Shu YS; Shi HC; Min LF
    Cancer Biol Ther; 2021 Apr; 22(4):324-332. PubMed ID: 33970779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Down-regulation of PHLPP1 expression ameliorates high glucose-induced autophagy inhibition and apoptosis promotion of podocytes by activating PI3K/AKT/mTOR pathway].
    Cai G; Zhang J; Wang R
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jan; 37(1):8-15. PubMed ID: 33441223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.